Elevated serum polyclonal immunoglobulin free light chains in patients with severe asthma

Area of Science:

• Immunology
• Pulmonology
• Biochemistry

Background:

• Inflammation is central to asthma pathophysiology.
• Free light chains (FLC) can trigger inflammation via mast cell activation.
• Previous studies indicated elevated serum immunoglobulin kappa (κ) FLC in adult males with asthma.

Purpose of the Study:

• To investigate the relationship between serum immunoglobulin (Ig) FLC concentrations and asthma severity.
• To explore the correlation of serum Ig FLC with various inflammatory markers in asthma patients.

Main Methods:

• Cross-sectional observational study measuring serum κ and λ Ig FLCs in severe, moderate, and mild persistent asthma patients, and healthy controls.
• Immunoassays were used to quantify FLC levels.
• Measurements included total/specific IgE, fractional exhaled nitric oxide (F_ENO), lung function, peripheral blood cell counts (eosinophils, neutrophils), and C-reactive protein (CRP).

Main Results:

• Serum κ FLC were significantly elevated in severe asthma compared to mild asthma and healthy subjects.
• Serum λ FLC were higher in severe asthma patients than in healthy controls and correlated with blood eosinophil counts.
• In severe asthma, serum Ig FLC correlated with CRP and neutrophil counts, and were elevated in patients with blood eosinophilia, but not with atopy. FLC levels were negatively correlated with lung function (FEV1 and FEV1/FVC ratio).

Conclusions:

• Serum Ig FLC levels are elevated in adults with severe asthma.
• These findings suggest that serum Ig FLC may serve as novel surrogate markers for inflammation in severe asthma.
• Further research is warranted to elucidate the pathophysiological implications of these findings.